Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
Global Markets for Machine Learning in the Life Sciences
... regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections from 2022 through 2027 and profiles key market players. BCC Research analyzes each technology in detail, determines major players ... Read More
-
Organ-on-chip Market, 2022-2035: Focus on Products and Technologies
... of effective preclinical prediction of drug responses in humans is one of the various reasons for drug’s failure to get approved. Animal testing for preclinical evaluation of drugs sometimes fails to identify toxicity signs caused ... Read More
-
Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification, and Lead Optimization), and By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Small molecule drugs have represented some of the crucial blockbusters in the ... Read More
-
Drug Discovery Market Forecasts to 2028 – Global Analysis by Technology (Nanotechnology, High Throughput Screening, Combinatorial Chemistry, Pharmacogenomics, Bioanalytical Instruments, Biochips, Bioinformatics and Other Technologies), Service (Medicinal Chemical Services, Biological Services, Drug Metabolism and Pharmacokinetics (DMPK) Services and Other Pharmaceutical Services), Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Therapeutic Area (Respiratory Disease, Neurology, Infectious and Immune System Diseases, Oncology, Cardiovascular Diseases, Digestive System Diseases, Diabetes and Other Therapeutic Areas) , End Use and By Geography
... (DMPK) Services and Other Pharmaceutical Services), Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Therapeutic Area (Respiratory Disease, Neurology, Infectious and Immune System Diseases, Oncology, Cardiovascular Diseases, Digestive System Diseases, Diabetes ... Read More
-
Automated Liquid Handling Technologies Market Forecasts to 2028 – Global Analysis By Product Type (Standalone Automated Liquid Handlers, Microplate Reagent Dispensers, Multi Instrument System, Automated Liquid Handling Workstation, Workstation Module, Reagents & Consumables, Pipettes & Consumables, Individual Benchtop Workstation, Specialized Liquid Handler, Burettes, Other Products), Connectivity (Wired Connection, Wireless Connection), Modality (Disposable Tips, Fixed Tips), Type (Electronic Liquid Handling Systems, Automated Liquid Handling Systems, Manual Liquid Handling Systems), procedures (Array Printing, Plate Reformatting, High Throughput Screening, PCR Setup, Whole Genome Amplification, Cell Culture, Serial Dilution, Plate Replication, Others), Application, End User and By Geography
... Consumables, Individual Benchtop Workstation, Specialized Liquid Handler, Burettes, Other Products), Connectivity (Wired Connection, Wireless Connection), Modality (Disposable Tips, Fixed Tips), Type (Electronic Liquid Handling Systems, Automated Liquid Handling Systems, Manual Liquid Handling Systems), procedures (Array ... Read More
-
Live Cell Imaging Market, By Product (Equipment, Consumables, and Software and Services), By Application (Cell Biology, Developmental Biology, Stem Cell Biology, Drug Discovery, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Live cell imaging is the study of living cells using time-lapse microscopy. This technique has revolutionized cell biology by facilitating ... Read More
-
PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... 1 (PD-L1) inhibitor are therapeutic agents that inhibit binding together of these checkpoint proteins on immune cells, eventually preventing tumors to escape the host immune defense mechanism and control the disease progression. The first PD-1 ... Read More
-
NLP in Healthcare and Life Sciences Market by Component (Solutions and Services), NLP Type (Statistical, Hybrid), NLP Technique (IVR, OCR), Application (Clinical Trail Matching, Drug Discovery), End Users and Region - Global Forecast to 2027
... The NLP in healthcare and life sciences market size to grow from USD 2.2 billion in 2022 to USD 7.2 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 27.1% during the forecast ... Read More
-
PCSK9 Inhibitors - Market Insight, Epidemiology and Market Forecast – 2032
... as the PCSK9i trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The PCSK9i market report provides emerging drugs, PCSK9i market share of the individual cancer types, current and ... Read More
-
Real World Evidence Solutions Market By Components (Data Sets, Consulting Services), By Application (Market Access and Reimbursement Coverage Decisions, Drug Development and Approvals, Post Market Surveillance, Medical Device Development and Approvals, Others), By End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global real-world evidence solutions market was valued at $1,369.3 million in 2021, and is projected to reach ... Read More
-
Federated Learning Market Share, Size, Trends, Industry Analysis Report, By Application (Industrial Internet of Things, Drug Discovery, Risk Management, Augmented and Virtual Reality, Data Privacy Management, Others); By Industry Vertical; By Region; Segment Forecast, 2022 - 2030
... - 2030 The global federated learning market size is expected to reach USD 266.77 million by 2030, according to a new study by Polaris Market Research. The report “Federated Learning Market Share, Size, Trends, Industry ... Read More
-
Europe Artificial Intelligence (AI) in Drug Discovery Market - Industry Trends and Forecast to 2029
... period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029. Market Segmentation Europe Artificial ... Read More
-
Biopreservation Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Media, LIMS); By Application (Regenerative Medicine, Bio-banking, Drug Discovery); By Cell Providers Volume; By Region; Segment Forecast, 2022 - 2030
... size is expected to reach USD 15.12 billion by 2030, according to a new study by Polaris Market Research. The report “Biopreservation Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Media, LIMS); By ... Read More
-
3D Cell Culture Market By Product (Scaffold Based Platforms, Scaffold Free Platforms, Gels, Bioreactors, Microchips, Services), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative medicine), By End User (Biotechnology and Pharmaceutical Companies, Contract Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031 A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022
... or in the pipeline. The data is assessed, and the different products are compared against each other both clinically and commercially. This report is an update of the previous COVID-19 Clinical and Commercial analyzer, which ... Read More
-
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Antecedent or F11 or EC 3.4.21.27) - Factor XI or plasma thromboplastin antecedent is the zymogen form of factor Xia. Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating ... Read More
-
Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Players, 2022 Update Summary Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) pipeline Target constitutes close to 19 molecules. Out of which approximately ... Read More
-
Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape. Hepatitis A is inflammation of the liver caused by hepatitis A virus. Symptoms include fatigue, nausea and vomiting, inflammation of the liver, loss of ... Read More
-
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characterization, Cell based Assays), By Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028
... Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028 Global Cancer Immunotherapy Drug Discovery Outsourcing Market is valued approximately ... Read More
-
Global Bioanalytical Testing Services, 2021–2027
... contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug development activities. Bioanalytical testing is one of the core aspects of drug development. The testing ... Read More
-
FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032
... expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032. The global FLT3 inhibitors market growth is expected to be driven by the ... Read More
-
Bioinformatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Bioinformatics Platforms, Knowledge Management Tools, and Bio Informative Services), Application (Genomics, Proteomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, and Others), and Sector (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Academics, Environmental Biotechnology, Forensic Biotechnology, and Others)
... (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Academics, Environmental Biotechnology, Forensic Biotechnology, and Others) The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is expected ... Read More
-
Global Animal Biotechnology Market Size study, segmented by Product Type (Vaccine, Drugs, Diagnostic Type, Reproductive And Genetic Product, Feed additives) by Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug development, others) Animal Type (Companion, Livestock) by End-Use (Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics)and Regional Forecasts 2022-2028
... development, others) Animal Type (Companion, Livestock) by End-Use (Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics)and Regional Forecasts 2022-2028 Global Animal Biotechnology Market is valued approximately USD 22.66 billion in 2021 and is anticipated to ... Read More
-
Digital Pathology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Scanners, Software, Storage, and Communication Systems), Type (Human Pathology and Veterinary Pathology), Application (Drug Discovery, Disease Diagnostics, Teleconsultation, and Training & Education), and End User (Pharma and Biotech Companies, Hospitals, and Academics)
... Education), and End User (Pharma and Biotech Companies, Hospitals, and Academics) The digital pathology market is expected to grow from US$ 952.62 million in 2022 to US$ 1,892.40 million by 2028; it is expected to ... Read More
Research Assistance
